FREMONT, CA--(MARKET WIRE)--Jul 31, 2007 -- Cardima, Inc. (OTC BB:CADM.OB - News), formerly (OTC BB:CRDM.OB - News), developer of the REVELATION® Tx, REVELATION® T-Flex ablation microcatheters and INTELLITEMP® Energy Management Device, announces today that its Board of Directors has declared a reverse stock split, at a 1 for 10 ratio, effective at the opening of trading on July 31, 2007. Following the split, the Company’s Common Stock will trade under a new ticker symbol, “CADM.” The Board declared this reverse stock split pursuant to the discretionary authority granted by the vote of a majority of the Company’s outstanding shares at the 2007 Annual Shareholders Meeting held June 28, 2007.
